Related Experiment Video
Updated: May 26, 2026

Cell Population Analyses During Skin Carcinogenesis
Published on: August 21, 2013
Combined effect of cyclin D3 expression and abrogation of cyclin D1 prevent mouse skin tumor development
Xian Wang1, Christopher Sistrunk, Paula L Miliani de Marval
1Department of Molecular Biomedical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, NC, USA.
Abstract:
We have previously demonstrated that ras-mediated skin tumorigenesis depends on signaling pathways that act preferentially through cyclin D1 and D2. Interestingly, the expression of cyclin D3 inhibits skin tumor development, an observation that conflicts with the oncogenic role of D-type cyclins in the mouse epidermis. Here, we show that simultaneous up and downregulation of particular members of the D-type cyclin family is a valuable approach to reduce skin tumorigenesis. We developed the K5D3/cyclin D1(-/-) compound mouse, which overexpresses cyclin D3 but lacks expression of cyclin D1 in the skin. Similar to K5D3 transgenic mice, keratinocytes from K5D3/cyclin D1(-/-) compound mice show a significant reduction of cyclin D2 levels. Therefore, this model allows us to determine the effect of cyclin D3 expression when combined with reduced or absent expression of the remaining two members of the D-type cyclin family in mouse epidermis. Our data show that induced expression of cyclin D3 compensates for the reduced level of cyclin D1 and D2, resulting in normal keratinocyte proliferation. However, simultaneous ablation of cyclin D1 and downregulation of cyclin D2 via cyclin D3 expression resulted in a robust reduction in ras-mediated skin tumorigenesis. We conclude that modulation of the levels of particular members of the D-type cyclin family could be useful to inhibit tumor development and, in particular, ras-mediated tumorigenesis.
Insights
Modulating D-type cyclins, specifically overexpressing cyclin D3 while reducing cyclin D1 and D2, significantly inhibits ras-mediated skin tumorigenesis in mice.
Area of Science:
- Oncology
- Molecular Biology
- Dermatology
Background:
- Ras-mediated skin tumorigenesis is linked to cyclin D1 and D2 signaling.
- Cyclin D3 expression typically inhibits skin tumor development, contrasting with other D-type cyclins.
- Understanding D-type cyclin family interactions is crucial for cancer research.
Purpose of the Study:
- To investigate the combined effect of modulating D-type cyclin family members on skin tumorigenesis.
- To develop and utilize a novel mouse model (K5D3/cyclin D1(-/-)) for studying these interactions.
- To determine if simultaneous upregulation of cyclin D3 and downregulation of cyclin D1/D2 can inhibit tumor formation.
Main Methods:
- Development of the K5D3/cyclin D1(-/-) compound mouse model.
- Overexpression of cyclin D3 and ablation of cyclin D1 in mouse skin keratinocytes.
- Analysis of cyclin D2 levels and keratinocyte proliferation.
- Assessment of ras-mediated skin tumorigenesis in the developed mouse model.
Main Results:
- The K5D3/cyclin D1(-/-) model showed reduced cyclin D2 levels, similar to K5D3 transgenic mice.
- Induced cyclin D3 expression compensated for reduced cyclin D1 and D2, maintaining normal keratinocyte proliferation.
- Simultaneous cyclin D1 ablation and cyclin D2 downregulation via cyclin D3 led to a significant reduction in ras-mediated skin tumorigenesis.
Conclusions:
- Modulating specific D-type cyclin family members is a viable strategy to inhibit skin tumor development.
- This approach shows particular promise for inhibiting ras-mediated tumorigenesis.
- Targeting D-type cyclin interactions offers potential therapeutic avenues in oncology.
Related Concept Videos
Inhibition of Cdk Activity
Abnormal Proliferation
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Replicative Cell Senescence

